Showing results (1-10 of 402) with videos related to
Sort By:
Pageof 41
Annals of Palliative Medicine|April 6, 2015
Expectations as outcome of effectiveness for patients with metastatic lung cancerAntonio Passaro, Filippo de MarinisRecenti Progressi in Medicina|December 21, 2016
[Nivolumab in second-line treatment of squamous non-small cell lung cancer.]Filippo De Marinis, Antonio PassaroRecenti Progressi in Medicina|April 20, 2016
[Immunotherapy in non-small cell lung cancer: evolution of knowledge and clinical advances]Alessia Pochesci, Antonio Passaro, Chiara Catania, et al.Journal of Thoracic Disease|April 15, 2016
Afatinib in first-line setting for NSCLC harbouring common EGFR mutations: new light after the preliminary results of LUX-Lung 7?Antonio Passaro, Alessia Pochesci, Gianluca Spitaleri, et al.Expert Review of Clinical Pharmacology|September 15, 2016
Afatinib for the first-line treatment of patients with metastatic EGFR-positive NSCLC: a look at the dataAntonio Passaro, Alessia Pochesci, Gianluca Spitaleri, et al.Oncotargets and Therapy|November 2, 2016
Personalized treatment in advanced ALK-positive non-small cell lung cancer: from bench to clinical practiceAntonio Passaro, Chiara Lazzari, Niki Karachaliou, et al.Expert Review of Anticancer Therapy|October 18, 2011
Second-line treatment of non-small-cell lung cancer: chemotherapy or tyrosine kinase inhibitors?Antonio Passaro, Enrico Cortesi, Filippo de MarinisJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2022
Neoadjuvant Chemotherapy Plus Immunotherapy in Early-Stage Resectable Non-Small-Cell Lung CancerAntonio Passaro, Ilaria Attili, Filippo de MarinisCancer Treatment Reviews|August 11, 2020
Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: A critical review of published dataAntonio Passaro, Ilaria Attili, Stefania Morganti, et al.Critical Reviews in Oncology/Hematology|September 8, 2025
Optimizing management of cutaneous toxicities from amivantamab in first-line non-small cell lung cancer: A clinical perspectiveIlaria Attili, Giulio Tosti, Francesca Pepe, et al.Pageof 41